Physician profile
Mark W Pittaluga
NPI 1538127956
$2,093.55
in general payments reported to CMS, 2019-2025
12 companies · $383 in 2025
The $383 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $254 · 2021: $154 · 2022: $169 · 2023: $487 · 2024: $646 · 2025: $383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,404 · Entertainment: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,403.84 |
| Entertainment | $112.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $648.94 | 2022-2025 | Infuse, Miebo, Xiidra |
| Johnson & Johnson Vision Care, INC. | $456.42 | 2019-2025 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $154.12 | 2021 | |
| Biotissue Holdings INC. | $130.96 | 2019 | |
| Glaukos Corporation | $118.77 | 2023 | |
| New World Medical,INC. | $113.67 | 2023 | |
| Optos, INC. | $112.58 | 2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Maculogix, INC. | $109.88 | 2019 | |
| Lkc Technologies, INC. | $98.93 | 2024 | |
| Alcon Vision LLC | $84.70 | 2024-2025 | Dailies Total1, Total30 |
| Topcon Healthcare, INC. | $36.20 | 2024 | |
| Coopervision INC. | $28.38 | 2024 | Myday Contact Lens |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Pittaluga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.